コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 cidence and prevalence in both developed and developing nations.
2 kin infections are particularly prevalent in developing nations.
3 atively low capacity for clinical studies in developing nations.
4 ageing of the population, particularly among developing nations.
5 ement of uremia-related CVD in developed and developing nations.
6 site sanitation between 1990 and 2010 for 21 developing nations.
7 ds causes public health harm concentrated in developing nations.
8 hundreds of thousands of deaths per year in developing nations.
9 y and mortality, particularly in children in developing nations.
10 range of infectious diseases, especially for developing nations.
11 munities and young scientists, especially in developing nations.
12 a significant component of health systems in developing nations.
13 ficant morbidity and mortality for humans in developing nations.
14 the potential postsurgical infections in the developing nations.
15 ain cause of mortality in industrialized and developing nations.
16 nsufficiency is common in industrialized and developing nations.
17 tinuum among social groups and developed and developing nations.
18 globe, in both industrialized countries and developing nations.
19 pproximately 50% of all malignancies in some developing nations.
20 nology available to vaccine manufacturers in developing nations.
21 ty for overall health systems improvement in developing nations.
22 for high infant and child mortality rates in developing nations.
23 nd mortality, particularly among children in developing nations.
24 uman diarrheal disease in both developed and developing nations.
25 ts incidence is frequently underestimated in developing nations.
26 are a leading cause of infantile diarrhea in developing nations.
27 n infectious illness acquired by visitors to developing nations.
28 y cost effective among immigrants from other developing nations.
29 d immigrants entering the United States from developing nations.
30 s attention on the health crises facing many developing nations.
31 creasing cause of morbidity and mortality in developing nations.
32 cancer are 176% higher in developed than in developing nations.
33 ificant source of morbidity and mortality in developing nations.
34 eneral population worldwide and blindness in developing nations.
35 s-SMPS -which is prohibitively expensive for developing nations.
36 ing with huge potential for public health in developing nations.
37 us disease with high fatality, especially in developing nations.
38 n coastal gillnet fisheries, particularly in developing nations.(5)(,)(21) Here we used controlled ex
39 For new immigrants to the United States from developing nations, a strategy of detecting and treating
41 atural lands could increase food security in developing nations and preserve much of Earth's remainin
42 ae continues to pose a health threat in many developing nations and regions of the world struck by na
43 erms of access to care between developed vs. developing nations and the uneven representation of IBD
46 viral therapy (ART) is being administered in developing nations at unprecedented numbers following th
47 is a common condition in both developed and developing nations, but its cause is largely unknown.
48 ted access to effective treatment options in developing nations cause delays in diagnosis and place a
49 in part responsible for mercury emissions of developing nations (e.g., China, India, and Indonesia).
50 ervices drives income-based GHG emissions of developing nations (e.g., China, Indonesia, India, and B
51 itiative data in resource rich developed and developing nations further showed improved hospital mort
52 though the accessibility of HIV treatment in developing nations has increased dramatically over the p
53 Poverty, the quintessential denominator of a developing nation, has been traditionally defined agains
54 indness and visual disability in many of the developing nations in Asia, Africa and the Middle East,
56 o affect water systems in both developed and developing nations, including India and the United Kingd
57 ll road construction is expected to occur in developing nations, including many regions that sustain
58 HIV therapy becomes more widely available in developing nations, it is clear that drug resistance wil
60 ency syndrome and other infectious diseases, developing nations must find ways to rapidly begin treat
62 nsferring transgenic plants or ag-biotech to developing nations, scientists from industrialized count
64 project that, without reductions in rapidly developing nations, such as investments to improve infra
65 incidence of urolithiasis is on the rise in developing nations; there is a need to address the most
66 on costs and environmental pollution and, in developing nations, they would improve food security and
68 taract extractions annually, particularly in developing nations where there is a large backlog of unt
69 expenditure in HIV-infected populations from developing nations, where concurrent malnutrition and co
70 te that risks are greatest for food-insecure developing nations, where feasible, sustainable, and soc
72 tory bowel disease is an uncommon disease in developing nations whereby patient's knowledge on the di
73 a primary constraint for crop production in developing nations, while in rich nations, intensive N f
74 knowledge and experience with hydroxyurea to developing nations with large medical burdens from SCA c
77 has recently increased in industrialized and developing nations, yet the population structure and vir